-
1 × $1,000.00 -
1 × $442.00 -
-
1 × $1,206.00 -
1 × $1,837.00 -
2 × $3,311.00 -
-
2 × $3,704.00 -
1 × $2,790.00 -
-
1 × $1,902.00 -
1 × $1,345.00 -
2 × $1,194.00 -
-
-
-
1 × $2,164.00 -
2 × $1,467.00 -
-
3 × $740.00 -
-
1 × $813.00
-
-
-
1 × $437.00 -
1 × $521.00
-
1 × $607.00 -
1 × $768.00 -
1 × $569.00 -
-
1 × $570.00 -
1 × $4,091.00 -
1 × $968.00 -
1 × $416.00 -
-
1 × $2,724.00 -
1 × $677.00 -
-
1 × $1,005.00 -
-
1 × $3,417.00 -
1 × $1,848.00 -
-
1 × $1,224.00 -
1 × $2,079.00 -
-
-
-
1 × $1,971.00 -
1 × $820.00 -
1 × $772.00 -
-
1 × $3,416.00 -
-
1 × $1,031.00 -
1 × $560.00 -
-
1 × $1,887.00 -
-
1 × $3,152.00 -
2 × $557.00 -
1 × $497.00 -
1 × $656.00 -
1 × $2,190.00 -
1 × $13,010.00 -
-
1 × $704.00 -
-
1 × $435.00 -
1 × $4,050.00 -
1 × $1,516.00 -
-
-
-
3 × $816.00 -
-
-
-
1 × $1,389.00 -
-
1 × $858.00
-
1 × $457.00 -
1 × $2,361.00 -
-
1 × $403.00
-
-
1 × $395.00
-
1 × $627.00 -
-
1 × $388.00 -
-
-
-
-
1 × $1,421.00 -
1 × $3,051.00 -
-
-
1 × $2,738.00 -
-
1 × $2,184.00 -
Roll over image to zoom in
This item can only ship to a medical or educational facility.
The new wireless BD Veritor™ Plus System gives health care providers and laboratorians in physician offices, clinics, hospitals and Integrated Delivery Networks (IDNs) with objective, lab-quality immunoassay test results within minutes. This fast and accurate solution streamlines the point-of-care (POC) diagnostic workflow and allows providers to quickly review patient results and determine the appropriate treatment in a single consultation. The new system can help detect infectious diseases such as influenza A and B, respiratory syncytial virus (RSV), COVID-19 (SARS-2-COV) and group A strep while the patient is still on site, which can enable faster decision making for an earlier intervention opportunity.
Features and Benefits
- Faster access to test results: Help inform appropriate and targeted treatment decisions.
- Improved Workflow: The BD Veritor™ Plus Analyzer improves workflow with an Analyze Now or Walk Away mode, providing test results (with a printenabled function) and aiding in decision making while the patient is onsite.
- Improved Traceability: The optional BD Veritor™ InfoScan module can scan 3 different identifiers (operator ID, specimen ID and test kit /lot) that can be locally recorded, printed or downloaded, and reduces hands-on time through automated documentation
- Modularity: Provides a unique solution to meet each testing site’s preference
- Advanced particle technology: Enhances sensitivity by using a proprietary process to produce highly stable, modified colloidal metal particles.
- Adaptive read technology: Compensates for background and non-specific binding helps improve specificity to reduce false-positive results
- BD Veritor SARS-CoV-2 & Flu A+B Rapid Detection Kit (Included): The BD Veritor System for Rapid Detection of SARS-CoV-2 is a chromatographic immunoassay for the direct and qualitative detection of SARS-CoV-2 antigens in nasal swabs from patients with signs and symptoms who are suspected of COVID-19.
Materials Included
- BD Veritor™ Plus System Anaylzer
- 2 AA Batteries
- 2 SARS-CoV-2 & Influenza A + B Rapid Detection Kit (30 Tests/Kits)
- User manual
CPT Code
- 87804-QW: Infectious agent antigen detection by immunoassay with direct optical observation, influenza A
- National Average Reimbursement: $16.00
- 878704-59: Infectious agent antigen detection by immunoassay with direct optical observation, influenza B
- National Average Reimbursement: $16.00
- 87426 – Infectious agent antigen detection by immunoassay technique (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative, multiple-step method, severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19])
